Fischer Medical Ventures Quarterly Results for Trading Insights
In Sept 2025, Fischer Medical Ventures (FISCHER) reported revenue ₹89 Cr and net profit ₹14 Cr — revenue +122.5% YoY. Also explore Fischer Medical Ventures share price performance to track price trends across different timeframes.
FISCHER Quarterly Results — Revenue, Profit & EPS Highlights
Fischer Medical Ventures latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with FISCHER stock valuation models to assess whether the stock is under or overvalued.
- Revenue of ₹89 Cr in Sept 2025 (+81.6% vs Mar 2025, +122.5% vs Sept 2024)
- Net Profit of ₹14 Cr in Sept 2025 (+1300.0% vs Mar 2025)
- EBITDA of ₹19 Cr in Sept 2025 (+533.3% vs Mar 2025)
- Operating Margin of 19.0% in Sept 2025 (+14.0pp vs Mar 2025)
- Earnings Per Share of ₹0.22 in Sept 2025 (+540.0% vs Mar 2025)
Fischer Medical Ventures Quarterly Results — Revenue, EBITDA, Net Profit & EPS
FISCHER quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 89 | 49 | 31 | 102 | 40 | 81.6% | 122.5% |
| Net Profit (₹ Cr) | 14 | 1 | 5 | 19 | 0 | - | - |
| EBITDA (₹ Cr) | 19 | 3 | 12 | 23 | 1 | - | - |
| EPS (₹) | 0.22 | -0.05 | 0.77 | 0.30 | 0.05 | - | - |
| Operating Margin (%) | 19.0% | 5.0% | 18.0% | 21.0% | 1.0% | - | - |
FISCHER Share Price Trend — 1-Year Movement Across Quarterly Results
Fischer Medical Ventures 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Fischer Medical Ventures share price chart.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
FISCHER vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap
Fischer Medical Ventures latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Pidilite Industries
Mar 2026 |
₹147,128.29 Cr | 1445.6 | 3,648 | 584 | +1.2% | +13.2% | 16.0% | 254.1 |
|
SRF
Mar 2026 |
₹79,892.42 Cr | 2695.2 | 4,557 | 582 | +28.0% | +7.2% | 12.8% | 137.3 |
|
Linde
Sept 2025 |
₹66,594.19 Cr | 7374.5 | 650 | 171 | +7.4% | - | 26.3% | 367.8 |
|
Fertilisers & Chemi…
Sept 2025 |
₹56,091.43 Cr | 874.5 | 1,681 | 21 | +48.8% | - | 1.2% | 2732.7 |
|
Coromandel Internat…
Mar 2026 |
₹54,887.50 Cr | 1860.5 | 6,068 | 115 | -37.9% | +11.1% | 1.9% | 391.7 |
All amounts in ₹ Crores